Filing Details
- Accession Number:
- 0001708138-17-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-18 17:00:32
- Reporting Period:
- 2017-08-16
- Filing Date:
- 2017-08-18
- Accepted Time:
- 2017-08-18 17:00:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1013064 | Roy P Vagelos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-08-16 | 84,613 | $0.00 | 329,543 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2017-08-16 | 153,969 | $21.92 | 483,512 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-08-16 | 7,159 | $471.41 | 476,353 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-08-16 | 75,406 | $471.41 | 400,947 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-08-16 | 10,986 | $470.17 | 389,961 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-08-17 | 1,305 | $470.00 | 388,656 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-08-18 | 2,900 | $470.15 | 385,756 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-03 | 422 | $0.00 | 150,285 | No | 5 | G | Indirect | by CLAT |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 5 | G | Indirect | by CLAT |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-08-16 | 153,969 | $0.00 | 153,969 | $21.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
153,969 | 2017-12-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,300 | Indirect | By 401(k) Plan |
Common Stock | 83,652 | Indirect | by Spouse as Trustee |
Common Stock | 1,203 | Indirect | by trust for grandch |
Footnotes
- Represents volume-weighted average price of sales of 10,986 shares of Company stock on August 16, 2017 at prices ranging from $470.00 to $470.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2017 at each separate price.
- Represents volume-weighted average price of sales of 1,305 shares of Company stock on August 17, 2017 at prices ranging from $470.00 to $470.03. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 17, 2017 at each separate price.
- Represents volume-weighted average price of sales of 2,900 shares of Company stock on August 18, 2017 at prices ranging from $470.00 to $470.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 18, 2017 at each separate price.
- By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.